MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in
cash, cash...
-$147,272K
Maturities of marketable
securities
$27,135K
Stock-based compensation
expense
$3,860K
Accounts payable
$858K
Depreciation expense
$338K
Proceeds from issuance of
common stock under...
$21K
Net cash used in
investing activities
-$128,210K
Net cash used in
operating activities
-$18,750K
Net cash used in
financing activities
-$312K
Canceled cashflow
$27,135K
Canceled cashflow
$5,056K
Canceled cashflow
$21K
Purchases of marketable
securities
$155,337K
Net loss
-$18,891K
Payments of offering
costs associated with...
$333K
Purchases of property and
equipment
$8K
Accrued expenses and
other liabilities
-$3,766K
Net accretion of
discounts on marketable...
$767K
Operating lease assets and
liabilities
$195K
Prepaid expenses and
other current assets
$179K
Other assets
$8K
Back
Back
Cash Flow
Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. (FULC)
source: myfinsight.com